Novartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia Read more
Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19 Read more
Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 Read more